MoonLake Immunotherapeutics (MLTX)
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.
Address
DORFSTRASSE 29
ZUG, V8 6300
Founded
2021
Number of Employees
50
Website
http://www.moonlaketx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)